Key facts
- This page summarizes Sandra Milligan's Form 4/A - Amendment filing for Aspira Women's Health Inc. (AWHL).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Jan 2025, 17:20.
Sandra Milligan - 31 Dec 2024 Form 4/A - Amendment Insider Report for Aspira Women's Health Inc. (AWHL)
- Reporting relationship
- Interim CEO
- Issuer ticker
- AWHL
- Reported as of
- 31 Dec 2024
- Net transaction value
- -$4,449
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 29 Jan 2025, 17:20:58 UTC
- Original report date
- 08 Jan 2025
- Prior SEC filing
- 13 Nov 2024
- Next SEC filing
- 02 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sandra Milligan
Source evidence
Original filing metadata and source links for verification.
6 source fields
Reporting owner
1 detail
Key filing fact
Sandra Milligan filed Form 4/A - Amendment for Aspira Women's Health Inc. (AWHL) on 29 Jan 2025.
Change
- Previous filing in this sequence was filed on 13 Nov 2024.
- Current net transaction value: -$4,449.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AWH
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +20,000
- Change %
- Price
- $0.000000
- Shares after
- 20,000
- Date
- 31 Dec 2024
- Ownership
- Direct
- Footnotes
- F1
AWH
transaction
Common Stock
Tax liability
- Transaction value
- $4,449
- Shares
- -6,356
- Change %
- -32%
- Price
- $0.7000
- Shares after
- 13,644
- Date
- 08 Jan 2025
- Ownership
- Direct
- Footnotes
- F2, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AWH
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- +20,000
- Change %
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on October 28, 2024.
Footnote F2
This line reflects the tax withholding on the vesting of RSUs that vested on December 31, 2024.
Footnote F3
Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock.
Footnote F4
On October 28, 2024, the reporting person was granted 20,000 RSUs, which vested on December 31, 2024. The common stock into which such vested RSUs converted on December 31, 2024 is reported in Table I on this Form 4.
Footnote F5
This report is being filed to correct the number of shares held after tax withholding on the vesting of RSUs that vested on December 31, 2024.